Wall Street is upgrading targets across tech and healthcare. The moves signal growing confidence after a mixed earnings season.
CSCO received the biggest bullish call of the day. Truist Securities analyst Matthew Niknam raised his target to $140, up from $125. He kept a Buy rating. Cisco's market cap stands near $488 billion. Short interest is low at 1.7% of free float. That combination suggests institutional appetite — not skepticism — is driving the stock.
COHR also drew fresh attention. Analysts lifted the consensus target to $409, up from $395. The photonics and laser maker has a $69.6 billion market cap. Short interest sits at just 5.3% of free float. Coherent has benefited from AI-linked demand for optical components.
CAH saw JP Morgan's Lisa Gill hike her target sharply — to $260 from $215. She kept a Hold rating. That is a $45 jump without an upgrade. It suggests the analyst sees Cardinal Health's value catching up to its price.
LLY and FDX both saw consensus targets tick higher. Eli Lilly's average target rose to $1,313. FedEx's moved to $356.
PWR and TRGP also received target increases, reflecting continued strength in infrastructure and energy midstream names.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
